Moneta Group Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Sell
10,011
-186
-2% -$26K 0.01% 314
2025
Q4
$1.25M Buy
10,197
+1,172
+13% +$142K 0.01% 324
2025
Q3
$1M Sell
9,025
-2,070
-19% -$235K 0.01% 354
2025
Q2
$1.23M Sell
11,095
-200
-2% -$21.3K 0.01% 281
2025
Q1
$1.27M Buy
11,295
+557
+5% +$57.5K 0.02% 260
2024
Q4
$992K Buy
10,738
+47
+0.4% +$4.23K 0.01% 285
2024
Q3
$896K Sell
10,691
-14
-0.1% -$1.07K 0.01% 293
2024
Q2
$734K Sell
10,705
-74
-0.7% -$4.94K 0.01% 315
2024
Q1
$790K Sell
10,779
-949
-8% -$73K 0.01% 294
2023
Q4
$950K Buy
11,728
+1,258
+12% +$97.9K 0.02% 246
2023
Q3
$785K Buy
10,470
+340
+3% +$26.2K 0.02% 252
2023
Q2
$781K Sell
10,130
-874
-8% -$69.7K 0.02% 253
2023
Q1
$913K Buy
11,004
+745
+7% +$61.7K 0.02% 226
2022
Q4
$861K Sell
10,259
-180
-2% -$14.3K 0.02% 218
2022
Q3
$644K Buy
10,439
+52
+0.5% +$3.28K 0.02% 239
2022
Q2
$642K Sell
10,387
-328
-3% -$20.3K 0.02% 265
2022
Q1
$637K Buy
10,715
+400
+4% +$25.6K 0.03% 262
2021
Q4
$749K Sell
10,315
-2,799
-21% -$193K 0.03% 242
2021
Q3
$916K Sell
13,114
-34,170
-72% -$2.4M 0.04% 202
2021
Q2
$3.26M Buy
47,284
+1,113
+2% +$74.3K 0.15% 105
2021
Q1
$2.98M Buy
46,171
+3,775
+9% +$243K 0.16% 101
2020
Q4
$2.47M Sell
42,396
-522
-1% -$31.5K 0.18% 88
2020
Q3
$2.71M Sell
42,918
-726
-2% -$50.3K 0.24% 75
2020
Q2
$3.36M Buy
43,644
+840
+2% +$64.4K 0.32% 62
2020
Q1
$3.2M Buy
42,804
+930
+2% +$64.3K 0.33% 60
2019
Q4
$2.72M Sell
41,874
-4,402
-10% -$287K 0.23% 67
2019
Q3
$2.93M Sell
46,276
-4,686
-9% -$306K 0.27% 66
2019
Q2
$3.44M Buy
50,962
+9,045
+22% +$595K 0.34% 51
2019
Q1
$2.73M Sell
41,917
-2,272
-5% -$151K 0.28% 63
2018
Q4
$2.76M Buy
44,189
+8
+0% +$559 0.33% 58
2018
Q3
$3.41M Sell
44,181
-8,817
-17% -$666K 0.35% 56
2018
Q2
$3.75M Buy
52,998
+7,925
+18% +$560K 0.42% 40
2018
Q1
$3.4M Sell
45,073
-3,336
-7% -$265K 0.45% 34
2017
Q4
$3.47M Sell
48,409
-4,726
-9% -$359K 0.52% 26
2017
Q3
$4.3M Sell
53,135
-4,103
-7% -$314K 0.67% 23
2017
Q2
$4.05M Sell
57,238
-2,172
-4% -$145K 0.66% 21
2017
Q1
$4.04M Sell
59,410
-4,055
-6% -$285K 0.8% 20
2016
Q4
$4.54M Buy
63,465
+8,604
+16% +$640K 0.93% 19
2016
Q3
$4.34M Sell
54,861
-200
-0.4% -$16.2K 0.99% 19
2016
Q2
$4.59M Hold
55,061
1% 18
2016
Q1
$5.06M Hold
55,061
1.12% 18
2015
Q4
$5.57M Buy
55,061
+4,321
+9% +$450K 1.37% 16
2015
Q3
$4.98M Buy
+50,740
New +$5.64M 1.39% 16
2015
Q2
Sell
-4,450
Closed -$437K 138
2015
Q1
$437K Buy
+4,450
New +$452K 0.19% 94
2014
Q4
Sell
-5,500
Closed -$585K 140
2014
Q3
$585K Sell
5,500
-66
-1% -$6.46K 0.3% 59
2014
Q2
$461K Sell
5,566
-894
-14% -$69.6K 0.25% 68
2014
Q1
$458K Sell
6,460
-2,450
-27% -$192K 0.27% 61
2013
Q4
$669K Sell
8,910
-5,600
-39% -$390K 0.4% 41
2013
Q3
$912K Sell
14,510
-100
-0.7% -$5.98K 0.6% 33
2013
Q2
$749K Buy
+14,610
New +$762K 0.53% 38

Other funds holding GILD

Moneta Group Investment Advisors's GILD Position: Q1 2026 in Review

Moneta Group Investment Advisors reduced its Gilead Sciences (GILD) stake by 1.8% in Q1 2026, selling an estimated $26K and leaving 10,011 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #314.

Moneta Group Investment Advisors first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $5.57M in Q4 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Moneta Group Investment Advisors held 10,011 shares of Gilead Sciences worth $1.4M as of Q1 2026.
  • Moneta Group Investment Advisors sold 186 Gilead Sciences shares in Q1 2026, an estimated $26K.
  • Gilead Sciences made up 0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #314 holding.
  • Moneta Group Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
  • Moneta Group Investment Advisors's Gilead Sciences position peaked at $5.57M in Q4 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.